Table 1 Clinical features (n = 43)
Contents | Patients | |
|---|---|---|
NO. | % | |
Sex | ||
Male | 39 | 90.7 |
Female | 4 | 9.3 |
Age (years) | ||
Range | 2-18 10.3 9 | |
Mean | ||
Median | ||
Sites | ||
abdomen | 20 | 46.5 |
Jaws and facial bones | 7 | 16.3 |
superficial lymph node | 7 | 16.3 |
tonsils | 3 | 7.0 |
nasopharynx | 3 | 7.0 |
inner canthus | 1 | 2.3 |
cerebellum | 1 | 2.3 |
peripheral blood & bone marrow | 1 | 2.3 |
B symptom | 17 | 39.5 |
Bulky disease | ||
<10 cm | 35 | 81.4 |
≥10 cm | 7 | 16.3 |
Lab findings (n = 34) | ||
anemia | 18 | 52.9 |
Increased WBC count | 12 | 35.3 |
Increased PLT number | 21 | 61.8 |
Increased serum level of LDH | 23 | 67.6 |
Staging (n = 43, Jude and Murphy) | ||
I / II | 8/20 | 19.1/47.6 |
III / IV | 9/6 | 21.4/11.9 |
IPI (n = 34) | ||
Low (0–2) | 24 | 70.6 |
High (3–4) | 10 | 29.4 |
Therapy (n = 30) | ||
Surgery alone | 10 | 33.3 |
Chemotherapy alone | 11 | 36.7 |
Surgery and chemotherapy | 9 | 30 |
Follow up (n = 43, months) | ||
Dead | 27 | 62.8 (average 4.9 m) |
Alive | 16 | 37.2 (average 48.7 m) |